PharmaGossip: Novartis Pays $422.5 Million to Settle Illegal Marketing of Trileptal - NYTimes.com
Links shared publicly online about this topic.
- 835total visits
PharmaGossip: Novartis Pays $422.5 Million to Settle Illegal Marketing of Trileptal - NYTimes.com
View full resource at pharmagossip.blogspot.com
Tags: Seizure Medication, Drug, Trileptal, Novartis, Epilepsy Medication
Most Recently Shared on September 30, 2010 at 10:08 pm By:
PharmaGossip: Novartis Pays $422.5 Million to Settle Illegal Marketing of Trileptal - NYTimes.com: The Swiss drug... http://bit.ly/bNlPKI
Novartis Unit Settles U.S. Charges Over Marketing - WSJ.com
online.wsj.com — “A U.S. subsidiary of Novartis has agreed to pay $422.5 million to resolve criminal and civil charges that it illegally marketed the epilepsy drug Trileptal and paid kickbacks to doctors.” View full resource at online.wsj.com
Most Recently Shared on October 1, 2010 at 2:48 pm By:
Novartis Unit to Pay $422.5 Million in Marketing Case: A U.S. subsidiary of Novartis has agreed to pay $422.5 mill... http://bit.ly/c1QM8m
Novartis Unit Settles U.S. Charges Over Marketing - WSJ.com
online.wsj.com — “A U.S. subsidiary of Novartis has agreed to pay $422.5 million to resolve criminal and civil charges that it illegally marketed the epilepsy drug Trileptal and paid kickbacks to doctors.” View full resource at online.wsj.com
Most Recently Shared on September 30, 2010 at 5:56 pm By:
Novartis Unit Settles U.S. Charges Over Marketing http://on.wsj.com/bISesY
Advertisement
